J. Goldman & CO LP Amicus Therapeutics, Inc. Put Options Transaction History

J. Goldman & CO LP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$9.55 - $12.09 $386,775 - $489,645	40,500 New	40,500 $432,000
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $1.55 Million - $1.92 Million	141,800 Added 150.05%	236,300 $2.62 Million
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $934,605 - $1.2 Million	94,500 New	94,500 $1.15 Million
Q2 2022 Aug 15, 2022	SELL	$6.23 - $11.12 $252,315 - $450,359	-40,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $319,545 - $505,440	40,500 New	40,500 $384,000
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $265,200 - $446,400	-40,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$7.48 - $10.75 $74,800 - $107,500	-10,000 Reduced 20.0%	40,000 $390,000
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $1.88 Million - $2.44 Million	-150,000 Reduced 75.0%	50,000 $720,000
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $2.35 Million - $3.16 Million	200,000	200,000 $3.02 Million

312

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.75B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.